Friday, November 20, 2009

8 – 8:30 a.m.
Registration
Continental Breakfast

8:30 – 8:40 a.m.
Welcome
Michael A. Friedman, M.D, President and Chief Executive Officer
Director, City of Hope Comprehensive Cancer Center

Opening Remarks
Richard Jove, Ph.D., Director, Beckman Research Institute

8:40 – 9:30 a.m.
Phenotypic Switching and the Molecular Anatomy of Tumor Progression
George Vande Woude, Ph.D., Van Andel Institute, MI

9:30 – 10:20 a.m.
Transcriptional Effects of Persistently Active STAT3 in Cancer Cells
James E. Darnell, Jr., M.D., The Rockefeller University, NY

10:20 – 10:40 a.m.
Break

10:40 – 11:30 a.m.
New Uses for Stem Cells in Understanding Neurodegenerative Disease
Lee L. Rubin, Ph.D., Harvard University, MA

11:30 a.m. – 12:20 p.m.
Signal Transduction in Cancer and the DNA Damage Response
Tony Hunter, Ph.D., Salk Institute for Biological Studies, CA

12:20 – 1:20 p.m.
Lunch – Courtyard

1:20 – 2:10 p.m.
Prodding and Engineering Cell Death Pathways
James A. Wells, Ph.D., University of California, San Francisco, CA

2:10 – 3 p.m.
Dissecting and Drugging Pathologic Protein Interactions with Hydrocarbon-Stapled Peptides
Loren D. Walensky, M.D., Ph.D., Harvard Medical School, MA

3 p.m. – 3:20 p.m.
Break

3:20 – 4:10 p.m.
New Frontiers in Molecular Medicine: Development of Proof-of-Concept Chemical Probes Targeting Selected Cysteine Proteases, Kinases, Orphan Nuclear Receptors and Carboxylate Transporters
William R. Roush, Ph.D., The Scripps Research Institute, FL

4:10 – 5 p.m.
A Chemical Approach to Stem Cell Biology
Peter G. Schultz, Ph.D., The Scripps Research Institute, CA

Registration is free.  Please register by November 6th online or by contacting the conference office to ensure your place. 

For more information, including a list of hotel accommodations, please contact: 

Steve Novak
Phone: 626-256-8775
Fax: 626-301-8105
beckmansymposium@coh.org